Subtypes of the type 4 cAMP phosphodiesterases: structure, regulation and selective inhibition
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Toxicology
Reference45 articles.
1. Phosphodiesterase IV Inhibitors as Therapy for Eosinophil-Induced Lung Injury in Asthma
2. Biarylcarboxylic Acids and -amides: Inhibition of Phosphodiesterase Type IV versus [3H]Rolipram Binding Activity and Their Relationship to Emetic Behavior in the Ferret
3. Discriminative stimulus properties of the stereoisomers of the phosphodiesterase inhibitor rolipram
4. Acute versus chronic administration of phosphodiesterase inhibitors on allergen-induced pulmonary cell influx in sensitized guinea-pigs
Cited by 149 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. PDE4DIP in health and diseases;Cellular Signalling;2022-06
2. Neuroinflammatory Response in Reward-Associated Psychostimulants and Opioids: A Review;Cellular and Molecular Neurobiology;2022-04-23
3. Effect of Roflumilast in airways disorders via dual inhibition of phosphodiesterase and Ca2+-channel;Saudi Pharmaceutical Journal;2020-06
4. Protective role of Roflumilast against cadmium-induced cardiotoxicity through inhibition of oxidative stress and NF-κB signaling in rats;Saudi Pharmaceutical Journal;2019-07
5. Apremilast prevent doxorubicin-induced apoptosis and inflammation in heart through inhibition of oxidative stress mediated activation of NF-κB signaling pathways;Pharmacological Reports;2018-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3